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Loss of heterozygosity occurs at the D11S29 locus on chromosome 11q23
in invasive cervical carcinoma
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Summary Allelotypic detection of loss of heterozygosity (LOH) has been used to identify putative tumour-
suppressor genes. Loci on human chromosome llq23 are frequently altered in malignant disease, and LOH
has been reported at an anonymous D I S29 locus at I 1q23 in a proportion of breast and ovarian cancers and
malignant melanomas. Previous studies have reported a high frequency of LOH in cervical carcinoma mapping
to 1 1q23. Using polymerase chain reaction techniques employing probes for a recently described polymorphic
dinucleotide microsatellite within this locus, we have searched for LOH in 69 cases of invasive cervical
carcinoma. Genomic material was microdissected from sections cut from archival paraffin-embedded material,
using the patients' constitutional genotype as a control Sixty-two (90%) of the cases were informative, and
LOH occurred in 25/62 (40%) of tumours. Loss of an arm or single chromosome 11 is a well-recognised event
in cervical carcinoma, and by employing other microsatellite polymorphisms mapping to I q13 and
lIpli -p12 we excluded those cases with widespread allelic loss. By doing so, LOH at D 1S29 was found in
16/53 (30%) of tumours. The findings suggest a putative tumour-suppressor gene on 1 lq involved in cervical
carcinogenesis.
Keywords: cervix neoplasms; human chromosome 11; loss of heterozygosity; tumour-suppressor genes; mic-
rosatellites; polymerase chai'n reaction
Cytogenetic and molecular biology studies ofhuman tumours
have identified chromosomal abnormalities, including dele-
tions of specific regions, that are associated with malignancy.
Many deletions are believed to involve loss of tumour-
suppressor genes, only a few of which have been cloned and
sequenced. In the tumour cell, mutation of a tumour-
suppressor gene is frequently accompanied by loss of the other
non-mutated allele together with portions of adjacent DNA
(Solomon et al., 1991). This DNA loss may be detected using
polymorphic markers for the affected locus and, where a
marker is informative, deletion of the locus on one
chromosome leads to loss of heterozygosity (LOH) for the
polymorphism. Analysis of LOH in tumours may be used to
indicate the chromosomal location of putative tumour-
suppressor genes.
Cytogenetic studies of cervical carcinoma show a high
degree of karyotypic variability, although the breakpoints
involved in the structural rearrangements are non-randomly
distributed (Atkin et al., 1990). Numerical changes together
with non-random deletions, inversions, isochromosome for-
mation and translocations are found to frequently involve
chromosome 11. The breakpoints here tended to cluster
around the locus llq23-q25 (Sreekantaiah et al., 1991).
LOH has been identified at a number of loci in cervical
cancer. Deletion mapping has shown loss at chromosome
3pl3-pl4.3 in 75% (Jones and Nakamura, 1992) and
3pl4-p21 in 100% (Yokota et al., 1989) of small series of
cervical carcinomas, with a suggestion of LOH at a locus
mapping to chromosome l7pl3 (Russell et al., 1992).
Restriction fragment length polymorphism (RFLP) studies
using probes that detect different polymorphisms have shown
a somatic loss of chromosome 11 heterozygosity in 30% of
primary cervical tumours (Srivatsan et al., 1991). Preliminary
data from this laboratory (Bethwaite et al., 1994) and others
(Hampton et al., 1994) have demonstrated a high frequency
of LOH (43-52%) at loci mapping to 1lq23 in cervical
tumours by RFLP and microsatellite polymerase chain reac-
tion (PCR) analysis.
LOH has been identified at an anonymous DlIS29 locus
on chromosome llq23 in a proportion of breast cancers
(60%) (Stickland et al., 1992) and cutaneous malignant
melanomas (67%) (Tomlinson et al., 1993). The 1 1q23 region
is of special interest in human oncogenesis, being frequently
altered in haematological malignancies, colorectal tumours
and ovarian cancer. Previously undertaken RFLP analysis
using probes for DlIS29 was hampered by low rate of
informativeness (Stickland et al., 1992; Tomlinson et al.,
1993). However this situation is greatly improved by the
identification of a highly polymorphic (GT)" microsatellite
variable number of tandem repeats (VNTR) within the locus
(Warnich et al., 1992). Using probes for this microsatellite
polymorphism, we have searched for LOH at locus DlIS29
on chromosome 1lq23 in 72 cases of invasive carcinoma of
the uterine cervix, using the patients' constitutional genotype
as a control.
Materials and methods
Materials
Eighty-one cases of invasive cervical carcinoma were
retrieved randomly from the archives of the Department of
Histopathology, John Radcliffe Hospital, UK (64 cases), and
the Department of Histopathology, Johannesburg General
Hospital, South Africa (17 cases). All material consisted of
formalin-fixed, routinely processed and paraffin wax-em-
bedded surgical specimens. Cases were selected to reflect a
balance of histological tumour type only. Nine cases (11%)
were excluded from the study as adequate constitutional
tissue was unavailable or the tumour tissue showed sig-
nificant necrosis which often inhibits the PCR.
DNA extraction
Six-micron-thick sections were cut from the tissue blocks
selected, fixed to glass slides, dewaxed, stained with
haematoxylin-eosin and dehydrated without a final xylene
step. Using a dissecting microscope, approximately 2 mm2 of
invasive tumour and constitutional tissue was microdissected
from the slide, using a modification of the technique of Pan
et al. (1994). The areas of interest were lifted from the slide
using a 22 gauge syringe needle fixed to a 1 ml insulin
syringe, under a drop of 50% ethanol. In the tumour tissue,
three sites were randomly selected from each case, comprising
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December 1994approximately 150-200 cells, and digested together. A
similar quantity of constitutional tissue was selected usually
from normal cervical epithelium, endometrium, pelvic lymph
nodes or ovarian tissue. Material from a wax blank was
included every 20 cases to exclude cross-contamination.
DNA was extracted in sterile microcentrifuge tubes in 25pl
of 100 mM Tris-HCI, 1 mM EDTA and proteinase K (Boeh-
ringer Mannheim) at a final concentration of 400 1ig ml-' at
55°C for 2 h; and heated to 95°C for 40 min. Combination of
the two steps was found to improve the yield of DNA
compared with either proteinase K digestion or heating
alone.
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DNA hybridisation
A subsample of cases were rerun on 12% non-denaturing
polyacrylamide gels and electrotransferred to charged nylon
membrane (Hybond-N+, Amersham) followed by UV light
fixing. The membranes were hybridised with a (CA)n
nucleotide repeat probe (Quick-Light probe, FMC) and the
products detected using a non-isotopic chemiluminescent
system (Quick-Light, FMC) on X-ray film.
Results
PCR technique
PCR was performed using oligonucleotide primers flanking
an informative (GT), microsatellite polymorphism at Dl S29
(Warnich et al., 1992). Reaction volumes were 50pl and the
reaction constituents are given in Table I. Taq polymerase
was added to each tube after heating samples in a Perkin-
Elmer Cetus thermal cycler to 94°C for 5 min. The samples
were cycled using a 'touchdown' technique, in which the
primer annealing temperature is reduced by 1°C every second
cycle until a final temperature is reached (Don et al., 1991).
The amplified product was visualised using a 16 x 16
cm x 0.75 mm, 12% non-denaturing polyacrylamide gel
(Sigma Chemicals, UK) run, with cooling, at 8 W for 5 h
(Protean II xi cell, Bio-Rad Laboratories, UK). The alleles
were revealed after staining with 0.5 pg ml-' ethidium
bromide and UV transillumination. In cases where a partial
loss was detected, the gel photograph was scanned into a
computerised image analysis system and the relative densities
of the allelic bands compared using appropriate software
(Quantiscan, Biosoft UK). Because of differential loading or
PCR amplification between tumour and normal samples,
relative allelic ratios were calculated using the technique out-
lined by Cawkwell et al. (1993). For a heterozygous sample,
the peak areas of the two dominant bands were calculated
for each constitutional (C) and tumour (T) sample, and the
relative allelic ratio calculated as [Tl:T2]/[Cl:C2], where TI
and Cl are the values derived from the shorter length allele
peak and T2 and C2 from the longer length peak. A priori, a
relative ratio of less than 0.50 was chosen as indicative of
LOH, based on previous studies (Cawkwell et al., 1993;
Orphanos et al., 1993; Hampton et al., 1994).
Informative cases identified as having LOH at Dl S29
were subject to further analysis using other informative mic-
rosatellite dinucleotide polymorphisms at loci on 1 1q13
(DllS534) (Hauge et al., 1991) and llpl2-pll.2 (DllS554)
(Phromchotikul et al., 1992). The PCR approach was similar;
the reaction conditions are given in Table I.
DNA amplification of the microsatellite polymorphism at
Dl lS29 from tumour and constitutional tissue was successful
in 69 of 72 cases. Despite repeated microdissections,
amplification failed from two tumours and one constitutional
case, presumably because of variations in fixation techniques.
Sixty-two (90%) of the cases were informative for the
Dl1S29 polymorphism. Results of the hybridisation on 20
cases using the (CA),, probe confirmed that the bands scored
corresponded to the dinucleotide repeat sequences of interest
(Figure 1).
Two patterns of loss were detected. The most common
pattern showed complete loss of one allele in the tumour
sample (16 cases) (Figure 2a). The other pattern showed
reduced intensity of one allele without complete loss owing to
contamination of the sample by tumour-infiltrating leuco-
cytes (14 cases) (Figure 2b). These 14 cases were subjected to
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Figure 1 (a) Ethidium bromide-stained polyacrylamide gel of
PCR products using primers flanking a microsatellite polymor-
phism at D1IS29, running between molecular weight markers at
147 and 180 bp, showing identifiable heterozygosity. (b) The same
case after DNA hybridisation with a (CA). repeat probe detected
by a chemiluminescent system, confirming that the bands seen in
a correspond to the dinucleotide polymorphism of interest. C,
constitutional tissue; T, tumour tissue.
Table I Parameters for polymerase chain reaction in the amplification of three
microsatellite polymorphisms on human chromosome 11
Parameters DIIS29 DJ15554 DIIS534
Extracted DNA 5Pl 5fl 5iLl
l0xreactionbuffera 5 1l 5dLI 10lPI
Primer concentrationb 12.5 pmol 12.5 pmol 12.5 pmol
dNTP concentration 25juM 60jLM 60gM
Taq polymerase 0.25 U 0.5 U 0.5 U
PCR cycle number/type 35/touchdown 40/touchdown 40/touchdown
Denaturing 94°C x 1 min 94°C x 1 min 94°C x 1 min
Annealing - iritial 72'C x 1 min 65°C x I min 65°C x 1 min
Annealing - final 61°C x 1 min 55°C x 1 min 55°C x 1 min
Extension 72°C x 1 min 72°C x 1 min 72°C x 1 min
Final elongation 72°C x 10 min 72°C x 10 min 72°C x 10 min
aI00mM Tris-HCI, 15 mm magnesium chloride, 500 mm potassiumchloride,0.1%
(w/v) gelatin, 1% Triton X-100. 'The primer sequences (from published data) are as
follows: D1 lS29primer 1, 5'-TCTAGCTCCACCATCCTGTG-3'; primer2, 5'-ACA-
ACACACTGCCACAAGAC-3' (Warnich et al., 1992); DI1S534 primer 1, 5'-ATA-
TGGAAACTCTCCGTACT-3'; primer 2, 5'-GCAACCATGGAGAGTCTGGA-3'
(Hauge et al., 1991); DIIS554 primer 1, 5'-GGTAGCAGAGCAAGACTGTC-3';
primer 2, 5'-CACCTTCATCCTAAGGCAGC-3' (Phromchotikul et al., 1992).Loss of heterozygosity incervical carcinoma
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Figure 2 Ethidium bromide-stained polyacrylamide gel of PCR
products using primers flanking a microsatellite polymorphism at
DIIS29 showing LOH in tumour tissue. (a) Complete loss of one
allele. (b) Reduced intensity of one allele resulting from con-
tamination of tumour tissue by inflammatory cells (relative allelic
ratio = 0.37). C, constitutional tissue; T, tumour tissue.
Table II LOH at DIlS29 in 53 cases ofinvasive carcinoma ofthecervix
according to HPV status, age at presentation and histological type
LOH No LOH X2a p
Age at presentation (years)
K40 7 13
>40 9 24 0.35 0.56
Histological tumour type
Squamous carcinoma 12 25
Adenocarcinoma 4 12 0.29 0.59
HPV status (PCR detected)
Positive 8 16
Negative 1 5 0.61 0.43
aMantel-Haenzel chi-squared.
11p |D11S554 0 0 0
* 0 0
D11S534 0 * 0 0 0 0
1llq
D11S29 0 * 0 0 0 0
n = 15 2 2 1 1 2 2 Total= 25 cases
*i =LOH
o =No LOH
0 = Non-informative
Figure 3 Deletion map of 25 cases of invasive carcinoma of the
uterine cervix which showed loss of heterozygosity at locus
D1 1S29 on chromosome 1 1q23.
computerised densitometry analysis. Using a relative allelic
ratio of less than 0.5 as a cut-off, 9/14 cases were categorised
as LOH. Therefore LOH at Dl 1S29 occurred in 25/62 (40%)
invasive cervical carcinomas.
Further allelic mapping of these 25 cases using the mic-
rosatellite polymorphisms at Dl 1S554 (1 lpl2-pl 1.2) and
DllS534 (1 1q13) gave informative results in 22/25 (88%) and
23/25 (92%) respectively. The LOH mapping obtained is
summarised in Figure 3. Assuming that loss of DNA at locus
Dl 1S534 and/or Dl 1S554 implies deletions of one arm or the
whole of chromosome 11, then LOH as a primary event at
Dl1S29 occurs in 16/53 cases (30%).
Information on human papillomavirus (HPV) infection
was available on 30 of these 53 cases based on PCR detection
(Bauer et al., 1992). No association was demonstrated
between the presence of LOH and HPV infection, patient age
at diagnosis and histological tumour type (Table II).
Discussion
Allelic loss had initially been detected in tumours using
RFLP techniques, which are limited by their expense, time
requirements, safety concerns, interpretative difficulties and
the high level of non-informative homozygous cases. Many
of these drawbacks have been overcome by the use of mic-
rosatellites (Cawkwell et al., 1993). These are short tandem
repeat sequences exhibiting length polymorphisms which
occur throughout the genome and which are highly infor-
mative. This study demonstrates that PCR analysis of mic-
rosatellite polymorphisms is easily --applied to routine
paraffin-embedded archival material to provide rapid and
sensitive detection of allelic imbalance. Allelic imbalance in
tumour tissue is a useful marker for putative allelic loss,
although as extracted DNA is not quantified the method
does not distinguish allelic deletions from mitotic recombina-
tion and allele amplification (Nordenskjold, 1990).
Traditionally, molecular analysis on archival material has
involved chemical genomic DNA extractions from whole tis-
sue sections, which often included invasive and in situ tumour
tissue together with a variable proportion of constitutional
tissue. In addition to obtaining widely varying amounts of
DNA from case to case, histological correlations were limited
and interpretation of allelic imbalance was subjective. In
order to circumvent these problems a range of microdissec-
tion techniques have been developed, which allow the selec-
tive identification and molecular analysis of cells of interest
(Whetsell et al., 1992; Lakhani et al., 1994; Pan et al., 1994).
The modified microdissection technique used in this study
was easy and cheap to apply after a short learning period. A
22 gauge syringe needle was found to be as useful and as
easy to manipulate as the micropipettes described by Pan et
al. (1994). Dissection under a drop of 50% alcohol prevented
any flaking and dispersion of tissue and at the same time
allowed the dissected tissue to clump and be easily lifted
from the slide. The major advantage of the technique was the
reduction in 'contamination' of tumour tissue by constitu-
tional cells, hence giving a largely clean pattern of allelic loss
in most instances.
Scoring of allelic loss using microsatellites is often under-
taken using radiographic techniques. However, a problem
with employing dinucleotide repeat polymorphisms is the
production of so-called 'stutter bands' caused by slippage of
the Taq polymerase in the PCR resulting in production of
smaller fragments and making autoradiographs difficult to
interpret. However, in the current study, by using a combina-
tion ofcareful optimisation of PCR reaction conditions, very
small quantities of PCR primers in each reaction and em-
ploying a 'touchdown' PCR technique, we found that 'stutter
bands' were minimised and that scoring was possible follow-
ing ethidium bromide staining alone.
This study adds to our preliminary report (Bethwaite et al.,
1994), the first to report allelic loss at locus DI1IS29 in
human cervical carcinoma, 40% of the cases studied showing
loss at this locus. We have made the conservative assumption
that additional LOH demonstrated using markers for other
loci on llp and/or 1lq indicate more general loss of a whole
or hemichromosome 11, and therefore these cases have been
excluded from further analysis. There is support for this
assumption using data from RFLP deletion mapping studies
(Srivatsan et al., 1991) and from cytogenetic studies of cer-
vical carcinoma which find such patterns of chromosomal 11
loss in between 10% and 30% oftumours (Atkin et al., 1990;
Sreekantaiah et al., 1991). After exclusion of these cases,
allelic loss at locus Dl1S29 occurred in 30% of cervical
tumours in our hands.
Despite cytogenetic data showing chromosome 11 to be
over-represented in structural aberrations in cervical malig-
nancy, there has been little previous work looking at the
molecular changes on chromosome 11. Srivatsan et al. (1991)
using RFLP analysis on 15 cases ofcervical carcinoma found
a diversity of loci deleted in six tumour samples, the majority
at sites on 1 lq, leading the authors to implicate the long arm
as a putative location for a cervical cancer tumour-Loss of heeroWgosity in cervical carcinoma
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suppressor gene. Hampton et al. (1994) reported on an allelic
mapping study of 32 cervical carcinomas using polymorphic
markers, the majority being PCR-detected microsatellite
polymorphisms on chromosome 11. This study found
evidence of clonal LOH for one or more markers on 1 lq in
14 cases; the highest frequencies were observed with
polymorphic loci at the Dl1IS144 locus (52%) and the
APOC3 gene (43%), both of which map to 1Iq23.
Foulkes et al. (1993), using microsatellite polymorphisms,
produced a deletion map of chromosome 1lq in 28 epithelial
ovarian tumours. At the Dl S29 locus they found LOH in 7
of 15 cases (47%). Interestingly, this study found a higher
rate of LOH at adjacent more distal loci, implying that the
area of maximum interest for a putative tumour-suppressor
gene is distal to the CD3D locus on 1 Iq23.3, which is some
1.8 cM distal from the Dl 1S29 locus. 1 1q23 has also been of
importance in haematological malignancies, with rearrange-
ments of this band being very common in acute leukaemias.
Here a number of translocations of the MLL gene (also
known as the ALL] or HRX gene) from l1q23 lead to the
creation of a fusion gene which encodes chimaeric oncogenic
proteins (Rowley, 1993). The role of 11q23 in proto-
oncogene activation in cervical malignancy remains to be
investigated.
How the existence of a tumour-suppressor gene on human
chromosome 1Iq fits into our current understanding of the
aetiology of cervical carcinoma is uncertain. It is known that
transfer of a single human chromosome 11 to either the
HeLa (Saxon et al., 1986) or SiHa (Koi et al., 1989) cervical
carcinoma cell lines suppresses the tumorigenic phenotype. It
is now appreciated that several subtypes of human papil-
lomavirus (HPV) occur frequently in cervical carcinoma and
its precursor lesions, and that viral integration into host
DNA affecting viral early (E) or late protein-encoding
regions appears important in the oncogenic process (Lane
and Wells, 1994). Compared with many other tumour types,
inactivation of the p53 gene by allelic loss or mutation is an
uncommon event in cervical carcinoma, however HPV E6
protein is known to bind to and neutralise normal p53
protein function. HPV integration sites have been shown to
be located on chromosomes close to oncogenes, fragile sites
and cancer chromosome breakpoints (Cannizzaro et al.,
1988), although chromosome 11 has not been implicated (De
Braekeleer et al., 1992). Interestingly, in experiments on
human fibroblast cells co-transfected with an HPV 16 DNA
containing plasmid with an activated EJ-ras oncogene, a
translocation, t(1:11), was found to be a frequent event; the
breakpoint was invariably at 1 1q23 (Matlashewski et al.,
1988). However, in the present series, LOH at Dl 1S29 was
not correlated with the presence of HPV as detected by PCR
techniques. It is likely that HPV integration is a necessary
but not sufficient precondition for cervical cancer, and there
is a synergistic role for other oncogenes including c-myc and
H-ras (Chen and Defendi, 1992). Loss or inactivation of
putative tumour-suppressor genes on chromosomes 3p
(Yokota et al., 1989; Jones and Nakamura, 1992) and 17p
(Russell et al., 1992) has been reported in a proportion of
cervical tumours, and the data from this and other studies
suggest that allelic loss in the region 1lq22-q24 may be
implicated in the chain of malignant transformation in the
cervix.
In summary, we have shown that loss of heterozygosity at
the Dl1S29 locus on human chromosome 1lq23 occurs in
40% of invasive cervical carcinomas. By excluding those
cases where LOH is occurring secondarily to loss of a whole
chromosome 11 or its long arm, then we find LOH at
DllS29 in 30% ofcervical carcinomas. Previous reports have
shown LOH at this site in other tumour types (Stickland et
al., 1992; Foulkes et al., 1993; Tomlinson et al., 1993) with a
high frequency of LOH at 1Iq22-q24 in small series of
ovarian and cervical carcinomas (Foulkes et al., 1993; Hamp-
ton et al., 1994), implicating a candidate tumour-suppressor
gene distally on chromosome 1lq. The findings in the current
study, while not providing a detailed deletion map of the 1 lq
region, are consistent with the involvement of chromosome
llq in cervical carcinogenesis. Further work is now under
way to produce a more detailed deletion map using other loci
on chromosome 1 1q23 and distal sites in an attempt to
pinpoint more accurately the region of interest. In addition,
it is important to examine the pattern of loss in high- and
low-grade cervical intraepithelial lesions to assess where
events on chromosome 11 are acting in the chain of cervical
malignant transformation.
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